Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02584478
Title Phase 1/2a Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)
Acronym AL3818
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Advenchen Laboratories, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP

Facility Status City State Zip Country Details
The Oncology Institute of Hope and Innovation Long Beach California 90805 United States Details
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Baptist Health Lexington Oncology Research Lexington Kentucky 40503 United States Details
Washington University Saint Louis Missouri 63130 United States Details
Montefiore Medical Center Bronx New York 10467 United States Details
AHN West Penn Hospital Pittsburgh Pennsylvania 15224 United States Details
UTSW Dallas Texas 75390 United States Details
University of Wisconsin Madison Madison Wisconsin 53792 United States Details
Henan Cancer Hospital Hefei Henan China Details
Jilin Cancer Hospital Changchun Jilin China Details
The First Hospital of China Medical University Shenyang Shenyang 110001 China Details
Zhongda Hospital Southeast University Chongqing Sichuan China Details
Tianjin Central Hospital of Gynecology Obstetrics Tianjin Tianjin China Details
Obstetrics&Gynecology Hospital of Fudan University Shanghai Yangpu District China Details
Beijing Cancer Hospital Beijing China Details
Chongqing University Cancer Hospital Chongqing China Details
Weifang People's Hospital Weifang China Details
National Cancer Institute IRCCS "G. Pascale" Foundation Naples Campania Italy Details
University Hospital of Bologna-IRCCS Bologna Emilia-Romagna Italy Details
Romagnolo Institute For the Study of Tumors "Dino Amadori" Meldola (FC) Forlì-Cesena 47014 Italy Details
Cannizzaro Emergency Hospital Catania Italy Details
Complex Structure Gynecology Oncology National Cancer Institute of Milan Milan Italy Details
Operative Unit of Oncology Ravenna 44266 Italy Details
Agostino Gemelli University Hospital Rome Rome Italy Details
Campus Bio Medico University Hospital Foundation Rome Italy Details
Severance Hospital Seoul, Korea, Republic of Details
Samsung Medical Center Seoul 05351 Korea, Republic of Details
Korea University Guro Hospital Seoul Korea, Republic of Details
Seoul National University Hospital Seoul Korea, Republic of Details
Hospital Universitario Reina Sofía Córdoba Andalucía Spain Details
Hospital Regional Universitario de Málaga Malaga Andalucía 29011 Spain Details
ICO Badalona Badalona Catalunya 08916 Spain Details
Hospital Universitari Vall d'Hebrón Barcelona Catalunya 08035 Spain Details
Hospital Clínico Universitario de Valencia Valencia Comunidad Valenciana Spain Details
Hospital Clínic de Barcelona Barcelona Spain Details
Hospital Universitario Ramón y Cajal Madrid 28034 Spain Details
Hospital Clínico San Carlos Madrid Spain Details
HCU Virgen Arrixaca Murcia 30120 Spain Details
Cambridge University Hospitals NHS Foundation Trust Cambridge Cambridgeshire United Kingdom Details
The Royal Marsden NHS Foundation Trust London United Kingdom Details
The Christie NHS Foundation Trust Manchester United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field